primary effusion lymphoma
Showing 1 - 5 of 5
s From HIV Infection, KSHV Infection, Viral-Related
Recruiting
- HIV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United
Active, not recruiting
- ALK-Positive Large B-Cell Lymphoma
- +34 more
- Nivolumab
- Varlilumab
-
Phoenix, Arizona
- +32 more
Jan 3, 2023
AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States
Completed
- AIDS-Related Plasmablastic Lymphoma
- +15 more
- Cyclophosphamide
- +8 more
-
Montgomery, Alabama
- +34 more
Feb 23, 2022
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma Trial (Pomalidomide,
Withdrawn
- Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
- Primary Effusion Lymphoma
- Pomalidomide
- +6 more
- (no location specified)
Aug 29, 2018